Union World Conference on Lung Health
October 11- 14, 2017
Expo Guadalajara Convention Centre | Guadalajara, Mexico
Luna will be presenting its pediatric friendly Anti-TB formulation development efforts during the upcoming Union World Conference on Lung Health, taking place in Guadalajara, Mexico from October 11-14 at the Expo Guadalajara Convention Centre.
The Union World Conference on Lung Health is the world’s largest gathering of clinicians and public health workers, health program managers, policymakers, researchers and advocates working to end the suffering caused by lung disease, with a focus specifically on the challenges faced by the low- and middle-income countries. Of the 10 million people who die each year from lung diseases, some 80 per cent live in these resource-limited countries. The theme this year: ‘Accelerating Toward Elimination’ will focus on multiple fronts including tuberculosis (TB) and co-infections, improving tobacco control, and reducing air pollution.
Tuberculosis (TB) is among the top 10 causes of death among children worldwide, however, children with TB are given low priority in most national health programs and are neglected in this epidemic. Nonadherence to treatment regimens is cited as a major barrier to the control and elimination of tuberculosis, and completion of drug therapy is critical to assure recovery and reduce development of drug-resistance, a major factor in TB treatment. Patient acceptability of a medicinal product is considered critically important for adherence, and can improve patient outcomes in pediatric patients. Luna Innovations Incorporated, with funding from the NIH/NIAID is working on development of pediatric friendly Anti-TB formulations that are stable under ambient conditions for 2 years while also being palatable to children.
Please join Blaine Butler at her interactive poster presentation PD-922-14 “Stability of anti-TB drugs in pediatric-friendly formulations”, Saturday October 14th at 12:45 – 13:45 pm in the Poster Area, Diagnosis and treatment: updates on pediatric TB.